Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of bioactive molecules and drug candidates. Its piperidine core protected by a BOC group and featuring a pyrrolidinocarbonyl substituent at the 4-position enables selective modifications in medicinal chemistry. This makes it valuable for creating protease inhibitors, central nervous system agents, kinase inhibitors, and other targeted therapies in oncology research. The BOC protecting group offers stability during synthesis and straightforward deprotection, supporting its application in solution-phase synthesis and the assembly of complex peptidomimetic structures.